Related Experiment Video
Updated: Apr 16, 2026
Protocol and Guidelines for Point-of-Care Lung Ultrasound in Diagnosing Neonatal Pulmonary Diseases Based on International Expert Consensus
Published on: March 6, 2019
Meconium aspiration syndrome: possible pathophysiological mechanisms and future potential therapies
Abstract:
Does meconium cause meconium aspiration syndrome (MAS) or is meconium discharge only a marker of fetal hypoxia? This dispute has lasted for centuries, but since the 1960s, detrimental effects of meconium itself on the lungs have been demonstrated in animal experiments. In clinical MAS, persistent pulmonary hypertension of the newborn is the leading cause of death in MAS. Regarding the complex chemical composition of meconium, it is difficult to identify a single agent responsible for the pathophysiology. However, considering that meconium is stored in the intestines, partly unexposed to the immune system, aspirated meconium could be recognized as ‘danger', representing damaged self. The common denominator in the pathophysiology could therefore be activation of innate immunity. Thus, a bulk of evidence implies that meconium is a potent activator of inflammatory mediators, including cytokines, complement, prostaglandins and reactive oxygen species. We hypothesize that the two main recognition systems of innate immunity, the Toll-like receptors and the complement system, recognize meconium as ‘danger', which leads not only to lung dysfunction but also to a systemic inflammatory response. This might have therapeutic implications in the future.
Insights
Meconium itself, not just fetal hypoxia, causes meconium aspiration syndrome (MAS). Innate immunity systems recognize aspirated meconium as danger, triggering inflammation and lung dysfunction.
Area of Science:
- Neonatalogy
- Pulmonology
- Immunology
Background:
- Meconium aspiration syndrome (MAS) is a significant cause of neonatal mortality.
- The exact role of meconium in MAS pathophysiology has been debated for centuries.
- Persistent pulmonary hypertension of the newborn is the primary cause of death in MAS.
Purpose of the Study:
- To investigate the role of meconium as a direct cause of MAS.
- To explore the underlying immunological mechanisms of meconium-induced lung injury.
- To identify potential therapeutic targets for MAS.
Main Methods:
- Review of existing literature on meconium's effects on the lungs.
- Analysis of meconium's complex chemical composition and its interaction with the immune system.
- Hypothesizing the involvement of innate immunity recognition systems.
Main Results:
- Evidence suggests meconium directly causes lung damage, not just a marker of fetal distress.
- Meconium activates inflammatory mediators like cytokines, complement, prostaglandins, and reactive oxygen species.
- Aspirated meconium may be recognized as 'danger' by the innate immune system.
Conclusions:
- Meconium is a potent activator of innate immunity, leading to lung dysfunction.
- Toll-like receptors and the complement system likely recognize meconium, initiating inflammatory responses.
- Understanding these mechanisms may lead to future therapeutic interventions for MAS.
More Related Videos
07:36Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats
Published on: November 20, 2015
08:50A Murine Model of Fetal Exposure to Maternal Inflammation to Study the Effects of Acute Chorioamnionitis on Newborn Intestinal Development
Published on: June 24, 2020
Related Concept Videos
01:23Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
01:20Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
01:20Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...